Influenza Clinical Trials Database - Free Access to 1,074 Studies
Access comprehensive clinical trial information for Influenza through Pure Global AI's free database. This collection includes 1,074 clinical trials across multiple phases including N/A, Phase 3, Phase 2. Currently, 50 trials are actively recruiting participants.
Research for Influenza is being conducted in United States of America, China, United Kingdom and 7+ other countries. Leading sponsors include GlaxoSmithKline and National Institute of Allergy and Infectious Diseases (NIAID). Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
A study to see the effect of Trivalent and Quadrivalent formulations of FluMist on the immune response of children 24 to < 48 months of age
This Study Will Evaluate the Safety, Tolerability, Activity of the Drug in the Body and Effectiveness of Baloxavir Marboxil Given as Granules in a Single Dose to Otherwise Healthy Children with Influenza
The administration of adjuvanted Trivalent Influenza Vaccine (aTIV) has come to result in a more immunogenic and effective response compared with conventional influenza vaccines in elderly and adults.
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza With a Focus on (H1N1) 2009 Flu Strain
A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza
Safety and Immunogenicity of Two 0.25 mL or 0.5 mL Doses of Two Different Influenza Vaccines in Healthy Children Aged 6 to <60 Months.
Safety, and Immunogenicity of Two Influenza Vaccines in Healthy Subjects 3 to 64 Years Old
This study will evaluate the effectiveness of a single dose of Baloxavir Marboxil to prevent the spread of influenza virus infection
A Phase 3/3b, Randomized, Observer-blind, Multicenter Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Subunit Inactivated Influenza Vaccine Compared to a Quadrivalent Influenza Vaccine in Adults ≥65 Years of Age
A Phase III, Randomized, Observer-blind, Multicenter Study to Evaluate the Efficacy, Immunogenicity and Safety of Seqirus’ Cell-Based Quadrivalent SubunitInfluenza Virus Vaccine (QIVc) Compared to a Non-Influenza Vaccine when Administrated in Healthy Subjects aged 6 Months through 47 Months
A phase II study, performed over a period of approximately 20 months,
A Clinical Trial of Quadrivalent Influenza Virus Split Vaccine (MDCK Cells) for Individuals Aged 6 Months and Above.
Digital Storytelling to Reduce Pediatric Influenza Vaccination Disparities
Evaluation of a Screen and Treat Protocol for Influenza
Phase 1 Evaluation of H1 Influenza Vaccine Delivered by MIMIX MAP
HD vs SD Quadrivalent Influenza Vaccine in Adults Aged 65 to 79 Years in Galicia
Study to Assess the Effect of Multistrain Probiotic on the Immune Response to the Influenza Vaccination
A Surveillance Study of Susceptibility to Baloxavir Marboxil in Participants With Influenza
Clinical Trial to Evaluate the Immunogenicity of an Adjuvanted Influenza Vaccine Among HCP
Pure Global AI provides free access to 1,074 clinical trials studying Influenza, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include GlaxoSmithKline, National Institute of Allergy and Infectious Diseases (NIAID), Sanofi Pasteur, a Sanofi Company, among others.